Startup rakes in $315M to scale VBC in rural America

The latest stories trending on MedCity News.

Editor's Pick

Top Story Main Street Health Rakes In $315M to Scale Value-Based Care in Rural America Main Street Health announced the close of a $315 funding round at HLTH — some of the investors included UnitedHealthcare, Humana, Elevance, Centene and CVS. The startup, which scales value-based care in rural areas for both Medicare Advantage and original Medicare patients, also announced that it is expanding to 26 states. Sponsored Content Navigating Healthcare's Data Revolution: Priorities, Opportunities, and Challenges for Health Systems Presented by Arcadia Arcadia recently partnered with HIMSS Market Insights to survey executives, IT, technology, and clinical leaders. Here's what we found. Learn More.

Featured News

Payer Insights Program Highlights How Payers and Tech Partners Are Thinking About AI, Health Equity, and the Consumer Experience HLTH 2023 introduced a new program focused on technology trends for and perspectives from payers in a series of conversations around AI, health equity and healthcare innovation. Sanofi Adds Biologics to Its AI Ambitions, Striking Up R&D Alliance With BioMap Formed by Baidu founder and CEO Robin Li, BioMap uses artificial intelligence technology to glean insight into proteins to guide biologic drug discovery. The startup is the latest company to join a growing list of Sanofi partners as the pharmaceutical giant continues investing in AI-enabled drug discovery. Highmark Health, Spring Health Team Up for Mental Health Solution Spring Health and Highmark Health are collaborating to launch Mental Well-Being, a solution that offers therapy, medication and other services for some Highmark members. Bayer's New $250M Cell & Gene Therapy Site Signals More Investments to Come Bayer opens its new cell therapy manufacturing facility as it prepares a Parkinson's disease cell therapy for Phase 2 testing. The new 100,000 square foot facility also has space for manufacturing other cell therapies in the pharma giant's pipeline.

Resources

MedCity Pivot Podcast: Tackling Rare Disease With Someone Who Was Touched By It Rich Horgan believes that there's an alternative path to drug development that can lower costs and the time it takes to bring drugs to market. He is trying to apply it to the field of rare and ultra-rare diseases. Listen Now

MedCity News • PO Box 901 • New York, NY unsubscribe